Protocol Ledger

NCT04483479 · Phase II · TERMINATED

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover)

Interventional Phase II clinical trial protocol NCT04483479 sponsored by Enterin in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-07-30 Enrollment: 27 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04483479
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)27 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04483479
Protocol FieldVerified Registry Value
NCT IdentifierNCT04483479
Consolidated Lead SponsorEnterin
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusTERMINATED
Registered Enrollment27 participants (ACTUAL)
Registered Start Date2020-07-30
WhyStopped ClassificationInsufficient / Slow Accrual

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI